Etavopivat clinical trials
Also written FT-4202.
How each study uses etavopivat is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the etavopivat studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
12 studies that test it; most in 2024 (4)
| Year | Studies |
|---|---|
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 3 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 12 · Other 0
Often tested with
Tested in the same studies.
Digoxin (1) · Pitavastatin (1) · Metformin (1) · Midazolam (1) · Rosuvastatin (1)
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2, 1 in phase 3
Studies that test etavopivat, phase 3 first.
- Aug 2027A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell DiseasePhase 3 · Novo Nordisk A/S
- Aug 2027A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary StrokePhase 2 · Forma Therapeutics, Inc.
Studies
Open first, then newest update. How each study uses etavopivat is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 12
- A Study to Evaluate the Pharmacokinetics and Safety of Etavopivat in Pediatric Patients With Sickle Cell DiseaseRecruitingPhase 2Forma Therapeutics, Inc.NCT06198712Written as Etavopivat
- A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell DiseaseRecruitingPhase 3Novo Nordisk A/SNCT06612268Written as Etavopivat
- A Phase 2 Open-label Study to Evaluate the Activity of Etavopivat on Transcranial Doppler Velocities in Pediatric Patients With Sickle Cell Disease Who Are at Increased Risk for Primary StrokeRecruitingPhase 2Forma Therapeutics, Inc.NCT05953584Written as Etavopivat
- A Research Study of the Effect of Etavopivat on Other Drugs in Healthy ParticipantsCompletedPhase 1Novo Nordisk A/SNCT06813924Written as Etavopivat
- A Study of Etavopivat for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS)TerminatedPhase 2Forma Therapeutics, Inc.NCT05568225Written as Etavopivat
- A Research Study on Etavopivat in Participants With and Without Liver DiseaseCompletedPhase 1Novo Nordisk A/SNCT06336018Written as Etavopivat
- Study of the Effect of Etavopivat on Cerebral Hemodynamic Response in Children With Sickle Cell DiseaseCompletedPhase 2Novo Nordisk A/SNCT05725902Written as Etavopivat
- A Study of Etavopivat in Adults and Adolescents With Sickle Cell Disease (HIBISCUS)Active, not recruitingPhase 3Forma Therapeutics, Inc.NCT04624659Written as Etavopivat Tablets Low dose
- A Study on the Effect of Etavopivat on Heart Rhythm in Healthy ParticipantsCompletedPhase 1Novo Nordisk A/SNCT07023029Written as Etavopivat
- A Research Study Looking at a Single Dose of Etavopivat in Healthy Chinese ParticipantsCompletedPhase 1Novo Nordisk A/SNCT06581627Written as Etavopivat
- A Study of Etavopivat in Patients With Thalassemia or Sickle Cell DiseaseCompletedPhase 2Forma Therapeutics, Inc.NCT04987489Written as Etavopivat tablets
- A Research Study of the Effect of Food on Etavopivat in Healthy ParticipantsCompletedPhase 1Novo Nordisk A/SNCT06433661Written as Etavopivat
Codes
What other systems call etavopivat · ClinicalTrials.gg INT018198
- UNII (FDA) V4E0A9M44QETAVOPIVATOne source FDA
- NCI Thesaurus C176893EtavopivatOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | V4E0A9M44Q | ETAVOPIVAT | One source FDA |
| NCI Thesaurus | C176893 | Etavopivat | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.